PRE-CLINICAL IMMUNE RESPONSE AND SAFETY EVALUATION OF THE PROTEIN SUBUNIT VACCINE NANOCOVAX FOR COVID-19
T. N. M. Tran, B. May, T. T. Ung, M. K. Nguyen, T. T. Nguyen, V. L. Dinh, T. V. Tran, H. Khong, T. T. Nguyen, H. Q. H. Hua, V. A. Nguyen, T. P. Ha, D. L. Phan, T. A. Nguyen, T. N. Bui, , M. S. Do
This study evaluates the immune response and safety of the protein subunit vaccine Nanocovax in animal models, showing high immunogenicity and no adverse effects.
bioRxiv · Jul 20, 2021 · PreprintImmunology